Certain Warrants of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023. These Warrants will be under lockup for 46 days starting from 1-AUG-2023 to 16-SEP-2023.

Details:
The officers and directors have agreed with the placement agent to be subject to a lock-up period of forty-five (45) days following the date of closing of the offering pursuant to this prospectus. This means that, during the applicable lock-up period, the company and such persons may not offer for sale, contract to sell, sell, distribute, grant any option, right or warrant to purchase, pledge, hypothecate or otherwise dispose of, directly or indirectly, any of shares of common stock or any securities convertible into, or exercisable or exchangeable for, shares of common stock, subject to customary exceptions